Skip to main content
Lotus Pharm logo

Lotus Pharm — Investor Relations & Filings

Ticker · 1795 ISIN · TW0001795003 LEI · 984500BEECDBC04KP716 TW Manufacturing
Open in API
Filings indexed 2,732 across all filing types
Latest filing 2023-06-15 Board/Management Inform…
Country TW Taiwan
Listing TW 1795

About Lotus Pharm

http://www.lotuspharm.com.tw

Lotus Pharmaceutical Co., Ltd. is a global specialty organization focused on the development, manufacturing, and commercialization of high-barrier generic and specialty medicines. The company specializes in complex generics, with a primary focus on oncology, immunology, and addiction treatment. Its portfolio includes technically demanding products such as Lenalidomide, Suboxone, Nintedanib, and Vinorelbine, as well as an advancing pipeline of biosimilars and 505(b)(2) oncology candidates. Utilizing an integrated R&D and manufacturing platform, the company executes a "2x2" growth strategy centered on dual market expansion and product diversification. Its commercial footprint spans over 90 markets globally, maintaining a strong presence in the Asia-Pacific region and the United States. The company prioritizes high technical entry barriers and cost-effective therapeutic solutions to improve global patient access to essential medications.

Recent filings

Filing Released Lang Actions
公告本公司新選任審計委員會名單
Board/Management Information Classification · 100% confidence The document is a formal announcement from a listed company (1795 美時) regarding changes in the audit committee members. It specifies the old and new members, their titles, and the reason for the change (term expiration and re-election). There is no financial data, no report attached or referenced, and no mention of financial results or regulatory filings beyond the announcement of management changes. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management.
2023-06-15 Chinese
公告本公司112年股東常會決議解除新任董事競業禁止之限制
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a formal announcement from a listed company (1795 美時) regarding a resolution passed at the 2023 Annual General Meeting (股東常會) held on June 15, 2023. The content details the approval to lift competition restrictions on newly appointed directors, listing their names, titles, and related competitive activities. It includes voting results and compliance with company law. The document is not a full report but an announcement of a shareholder meeting decision and voting outcome related to board matters. It does not contain financial statements or detailed management discussion, nor is it a transcript or presentation. The key focus is on the shareholder meeting resolution and voting results. Therefore, the most appropriate classification is Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is under 5,000 characters and is a direct announcement, not a report publication notice or certification.
2023-06-15 Chinese
公告本公司112年股東常會董事全面改選當選名單
Board/Management Information Classification · 95% confidence The document is a formal announcement from a listed company (1795 美時) regarding the complete re-election of the board of directors at the 112th Annual General Meeting (股東常會董事全面改選當選名單). It details the old and new directors, their titles, resumes, shareholdings, and the effective date of the new appointments. There is no financial data or report content, only information about board member changes resulting from the AGM. This fits the definition of Board/Management Information (MANG) as it announces changes in the company's board of directors. The document length is under 5,000 characters and is a direct announcement, not a report or presentation. Therefore, the correct classification is MANG with high confidence.
2023-06-15 Chinese
公告本公司112年股東常會重要決議事項
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a formal announcement from a listed company (1795 美時) regarding the important resolutions made at its 2023 Annual General Meeting (股東常會). It lists key decisions such as dividend distribution, amendments to the company charter, approval of the business report and financial statements for the fiscal year 2022 (111年度), election of directors, and other shareholder meeting resolutions. The document is short (703 characters) and focuses on the results of the shareholder meeting rather than providing the full meeting materials or detailed financial reports. This matches the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA), which covers official results from shareholder votes at general meetings. It is not the full Annual Report (10-K) or the meeting presentation (AGM-R). Therefore, the correct classification is DVA with high confidence.
2023-06-15 Chinese
112年5月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a financial disclosure from a listed company providing details about fund loans and endorsement guarantees for the current and previous months, including limits and balances. It is a short report (626 characters) focused on specific financial data related to loans and guarantees, without comprehensive financial statements or management discussion. It does not announce or attach a full report but provides a snapshot of financial information. This type of disclosure aligns with a Regulatory Filing (RNS) as it is a general regulatory announcement about financial conditions without being a full report like an Annual or Interim Report.
2023-06-09 Chinese
112年5月營業收入
Fund Information / Factsheet Classification · 95% confidence The document is a revenue summary report from a listed company, showing monthly and cumulative net operating revenue figures with percentage changes and explanations for the changes. It is a brief financial data summary without detailed financial statements or comprehensive analysis. The document length is short (810 characters), and it does not contain full financial reports or management discussion. It is essentially a factsheet or summary of key financial figures for a specific period (May 2023). Therefore, it fits best into the category of Fund Information / Factsheet (FS), which covers brief summaries of key company financials and market info.
2023-06-09 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.